Drw Securities, LLC Travere Therapeutics, Inc. Transaction History

Drw Securities, LLC

  • $2.47 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$5.26 - $8.28 $61,005 - $96,031
11,598 New
11,598 $95,000
Q1 2021

May 13, 2021
SELL
$23.37 - $31.77 $2.34 Million - $3.18 Million
-100,000 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$19.17 - $27.87 $1.92 Million - $2.79 Million
100,000 New
100,000 $2.73 Million

Others Institutions Holding TVTX

# of Institutions
213
Shares Held
94.1M
Call Options Held
1.2M
Put Options Held
778K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.51B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Drw Securities, LLC Portfolio

Follow Drw Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drw Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email